How Bounded Health operates

We begin by quantifying your current GLP-1 pharmacy spend and projecting its trajectory under a no-intervention scenario. Analysis includes confidence ranges and assumes conservative estimates.

This assessment identifies the financial scale of the problem and establishes a baseline against which containment will be measured. No member-level data is required at this stage.

Output: Executive cost summary with projected spend in basis points of total pharmacy budget.

Eligible members are assessed for metabolic stability and taper readiness using structured protocols. The system operates continuously without requiring recurring client input.

Risk scoring is conservative. Members who do not meet stability thresholds are excluded from tapering consideration. Analysis is repeated at regular intervals to reflect changing member status.

Output: Clinical risk assessment with stability scores, confidence intervals, and taper eligibility.

Clinical tapering protocols, member communication, and prescriber coordination are handled as a managed service. Oversight is exception-based. Protocols are executed systematically, with human judgment applied where required.

Members receive structured guidance. Prescribers receive protocol-compliant recommendations. Deviations from expected outcomes trigger review and protocol adjustment.

As protocols stabilize and outcomes become predictable, the level of human involvement decreases.

Output: Ongoing tapering management with quarterly outcome reporting.

Once protocols are validated and outcomes are stable, the system operates largely in the background. Reporting becomes quarterly. Client interaction is limited to reviews and approvals.

The service functions like other outsourced health plan operations: predictable, measurable, and invisible until intervention is required.

Output: Quarterly program reviews with cost reduction realized and forward projections.